BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9599864)

  • 1. Cost-effectiveness of measles outbreak intervention strategies.
    Shiell A; Jorm LR; Carruthers R; Fitzsimmons GJ
    Aust N Z J Public Health; 1998 Feb; 22(1):126-32. PubMed ID: 9599864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness analysis of measles outbreak control strategies.
    Davis RM; Markowitz LE; Preblud SR; Orenstein WA; Hinman AR
    Am J Epidemiol; 1987 Sep; 126(3):450-9. PubMed ID: 3113234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated.
    Sugerman DE; Barskey AE; Delea MG; Ortega-Sanchez IR; Bi D; Ralston KJ; Rota PA; Waters-Montijo K; Lebaron CW
    Pediatrics; 2010 Apr; 125(4):747-55. PubMed ID: 20308208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies.
    Mast EE; Berg JL; Hanrahan LP; Wassell JT; Davis JP
    JAMA; 1990 Nov; 264(19):2529-33. PubMed ID: 2122013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles outbreak in Juneau, Alaska, 1996: implications for future outbreak control strategies.
    Landen MG; Beller M; Funk E; Rolka HR; Middaugh J
    Pediatrics; 1998 Dec; 102(6):E71. PubMed ID: 9832599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in managing a school-based measles outbreak in Melbourne, Australia, 2014.
    Gibney KB; Brahmi A; O'Hara M; Morey R; Franklin L
    Aust N Z J Public Health; 2017 Feb; 41(1):80-84. PubMed ID: 27960246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of a measles outbreak by prohibiting non-vaccinated susceptible students from attending school in Akita Prefecture, Japan.
    Takimoto N; Takahashi Y; Ishiyama A; Kishimoto K; Iwama R; Nakano M
    Jpn J Infect Dis; 2011; 64(4):309-11. PubMed ID: 21788706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges related to resources mobilization for measles outbreak response: Madagascar experience during the 2018-2019 measles outbreak.
    Sodjinou VD; Nimpa MM; Douba A; Masembe YV; Randria M; Ndiaye CF
    Pan Afr Med J; 2020; 36():304. PubMed ID: 33282087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy.
    Robertson SE; Markowitz LE; Berry DA; Dini EF; Orenstein WA
    Public Health Rep; 1992; 107(1):24-31. PubMed ID: 1738804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.
    Parker AA; Staggs W; Dayan GH; Ortega-Sánchez IR; Rota PA; Lowe L; Boardman P; Teclaw R; Graves C; LeBaron CW
    N Engl J Med; 2006 Aug; 355(5):447-55. PubMed ID: 16885548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study.
    Takahashi K; Ohkusa Y; Kim JY
    BMC Health Serv Res; 2011 Oct; 11():254. PubMed ID: 21978107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Costs of Measles Outbreak in the Netherlands, 2013-2014.
    Suijkerbuijk AW; Woudenberg T; Hahné SJ; Nic Lochlainn L; de Melker HE; Ruijs WL; Lugnér AK
    Emerg Infect Dis; 2015 Nov; 21(11):2067-9. PubMed ID: 26488199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expensive adult measles outbreak and response in office buildings during the era of accelerated measles elimination, Beijing, China.
    Ma R; Lu L; Suo L; Li X; Yang F; Zhou T; Zhai L; Bai H; Pang X
    Vaccine; 2017 Feb; 35(8):1117-1123. PubMed ID: 28131395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015.
    Ramsay LC; Crowcroft NS; Thomas S; Aruffo E; Teslya A; Heffernan JM; Gournis E; Hiebert J; Jaeger V; Jiaravuthisan M; Sharron J; Severini A; Deeks SL; Gubbay J; Mazzulli T; Sander B
    Euro Surveill; 2019 Mar; 24(11):. PubMed ID: 30892178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of measles revaccination among school-entry-aged children.
    Watson JC; Pearson JA; Markowitz LE; Baughman AL; Erdman DD; Bellini WJ; Baron RC; Fleming DW
    Pediatrics; 1996 May; 97(5):613-8. PubMed ID: 8628596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A limited measles outbreak in a highly vaccinated US boarding school.
    Yeung LF; Lurie P; Dayan G; Eduardo E; Britz PH; Redd SB; Papania MJ; Seward JF
    Pediatrics; 2005 Dec; 116(6):1287-91. PubMed ID: 16322148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine.
    Vitek CR; Aduddell M; Brinton MJ; Hoffman RE; Redd SC
    Pediatr Infect Dis J; 1999 Jul; 18(7):620-3. PubMed ID: 10440438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.